Advisor Group’s Neos Therapeutics, Inc NEOS Stock Holding History

Advisor Group’s Portfolio NEOS Stock Details NEOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$20K	Hold	13,000	–	–	﹤0.01%	3975
2019 Q3	$19K	Hold	13,000	–	–	﹤0.01%	4002
2019 Q2	$17K	Buy	+13,000	New	+$23.9K	﹤0.01%	4087
2018 Q1	–	Sell	-1,000	Closed	-$10K	–	5138
2017 Q4	$10K	Sell	1,000 -1,100	-52%	-$10.6K	﹤0.01%	4115
2017 Q3	$19K	Buy	+2,100	New	+$16K	﹤0.01%	3594

Other funds holding NEOS

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Advisor Group's NEOS Position: Q4 2019 in Review

Advisor Group held its Neos Therapeutics, Inc (NEOS) position steady in Q4 2019 at 13,000 shares worth $20K. The position accounts for ﹤0.01% of the portfolio, ranked #3975.

Advisor Group first reported a position in NEOS in Q3 2017 and has held it in 5 quarters since. 54 funds tracked by Wall St. Rank hold NEOS as of Q4 2019.

Advisor Group held 13,000 shares of Neos Therapeutics, Inc worth $20K as of Q4 2019.
Advisor Group left its Neos Therapeutics, Inc share count unchanged in Q4 2019.
Neos Therapeutics, Inc made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #3975 holding.
Advisor Group first reported a position in Neos Therapeutics, Inc in Q3 2017 and has held it in 5 quarters since.
54 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.